Ethan B. Ludmir, M.D.

Peer-Reviewed Articles

1. Sherry, AD, Liu, Y, Msaouel, P, Lin, TA, Koong, A, Lin, C, Abi Jaoude, J, Patel, RR, Kouzy, R, El Alam, MB, Miller, AM, Owiwi, M, Ofer, J, Bomze, D, McCaw, ZR, Meirson, T, Ludmir, EB. Survival-inferred fragility of statistical significance in phase III oncology trials. npj Precision Oncology 9(1), 2025. e-Pub 2025. PMID: 40707724.
2. Sherry, AD, Msaouel, P, Miller, AM, Lin, TA, Kupferman, GS, Abi Jaoude, J, Kouzy, R, El Alam, MB, Patel, RR, Koong, A, Lin, C, Meirson, T, McCaw, ZR, Ludmir, EB. Bayesian interim analysis and efficiency of phase III randomized trials. British journal of cancer 133(8):1145-1151, 2025. e-Pub 2025. PMID: 40789942.
3. Owens, CA, Ludmir, EB, Liu, Q, Qiu, W, Gupta, AC, Smith, SA, Rigaud, B, Brock, K, Bates, JE, Meyers, TG, Paulino, AC, Peterson, CB, Kry, SF, Teepen, JC, Ronckers, CM, Neglia, JP, Leisenring, W, Oeffinger, KC, Nathan, PC, Turcotte, LM, Hodgson, DC, Hudson, MM, Robison, LL, Moskowitz, CS, Armstrong, GT, Henderson, TO, Yasui, Y, Howell, RM. Colorectal-Specific Radiation Dose and Chemotherapy Risk for Subsequent Colorectal Malignancies in Childhood Cancer Survivors. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 43(31):3403-3421, 2025. e-Pub 2025. PMID: 41032739.
4. Tang, C, Sherry, AD, Seo, A, Kobayashi, K, Choi, H, Liu, S, Sun, X, Montoya, A, Ludmir, EB, Shah, AY, Jonasch, E, Zurita-Saavedra, A, Kovitz, CA, Alhalabi, O, Goswami, S, Hahn, AW, Campbell, M, Hernandez, A, Nead, KT, Van Loo, P, Su, S, Battey, CJ, LaBella, ML, Ratzel, S, Acevedo, A, Genovese, G, Sircar, K, Karam, JA, Tannir, NM, Msaouel, P. Metastasis-directed radiotherapy without systemic therapy for oligometastatic clear-cell renal-cell carcinoma. The lancet oncology 26(10):1289-1299, 2025. e-Pub 2025. PMID: 40915303.
5. Sherry, AD, Msaouel, P, Miller, AM, Lin, TA, Abi Jaoude, J, Kouzy, R, Passy, AH, Meirson, T, Ignatiadis, N, McCaw, ZR, van Zwet, E, Ludmir, EB. Reproducibility of statistically significant phase III oncology trials. European Journal of Cancer 226, 2025. e-Pub 2025. PMID: 40628175.
6. Brown, G, Msaouel, P, Miller, AM, Kouzy, R, Lin, TA, Abi Jaoude, J, Ludmir, EB, Sherry, AD. Patient, Physician, and Assessor Blinding in Phase III Randomized Trials in Oncology. Cancer medicine 14(15), 2025. e-Pub 2025. PMID: 40879280.
7. Noticewala, SS, Grippin, A, Kouzy, R, Abi Jaoude, J, Miller, AM, Sherry, AD, Ludmir, EB. Effect size estimation in cooperative group- and industry-sponsored phase 3 oncology trials. Journal of the National Cancer Institute 117(8):1738-1742, 2025. e-Pub 2025. PMID: 40220316.
8. Miller, AM, Passy, AH, Sherry, AD, Kouzy, R, Abi Jaoude, J, Lin, TA, Kupferman, GS, Beck, EJ, Msaouel, P, Ludmir, EB. Incomplete Toxicity Reporting and Use of Toxicity-Minimizing Language in Phase III Oncology Trials. JCO Oncology Practice 21(7):979-988, 2025. e-Pub 2025. PMID: 39778122.
9. Morris, VK, Xiao, W, Lin, K, Wong, CW, Wotman, MT, Holliday, EB, Huey, RW, Noticewala, SS, Ludmir, EB, Bent, AH, Ludford, K, Messick, C, Koay, EJ, Smith, GL, Konishi, T, Bednarski, BK, Chang, GJ, Koong, A, You, YN, Das, P, Gillison, M. Time Dependency for Human Papillomavirus Circulating Tumor DNA Detection after Chemoradiation as a Prognostic Biomarker for Localized Anal Cancer. Clinical Cancer Research 31(12):2399-2405, 2025. e-Pub 2025. PMID: 39873618.
10. Averbuch, I, Bareket-Samish, A, Goldstein, DA, Eizenstein, S, Markel, G, Rosenbaum, E, Limon, D, Bomze, D, Ludmir, EB, Meirson, T. Challenges in Interpreting Survival Metrics in Clinical Trials. International Journal of Radiation Oncology Biology Physics 122(2):224-233, 2025. e-Pub 2025. PMID: 39978692.
11. Kleber, T, Sherry, AD, Arifin, AJ, Kupferman, GS, Kouzy, R, Abi Jaoude, J, Lin, TA, Beck, EJ, Miller, AM, Passy, AH, McCaw, ZR, Msaouel, P, Ludmir, EB. Justification, margin values, and analysis populations for oncologic noninferiority and equivalence trials. Journal of the National Cancer Institute 117(5):898-906, 2025. e-Pub 2025. PMID: 39657246.
12. Yu, C, Gay, SS, Gupta, AC, Martin, RM, Ludmir, EB, Zhao, Y, Duryea, J, Chen, X, Cardenas, CE, Yang, J, Koong, A, Netherton, T, Rhee, DJ, Court, LE. Uncertainty-guided pancreatic tumor auto-segmentation with Tversky ensemble. Physics and Imaging in Radiation Oncology 34, 2025. e-Pub 2025. PMID: 40276495.
13. Kuehnle, RA, Tchelebi, LT, Ludmir, EB, Escorcia, FE, Shrestha, S, Sanford, NN, Court, CM, Ryckman, JM, Arora, SP, Lehrer, EJ, Gelfond, J, Jethwa, K, Newman, NB. Meta-analysis of randomized controlled trials of external-beam radiation versus transarterial chemoembolization for hepatocellular carcinoma. Cancer 131(3), 2025. e-Pub 2025. PMID: 39887736.
14. Seo, YD, Acidi, B, Newton, A, Haddad, A, Chiang, YJ, Coelho, R, Newhook, TE, Tzeng, CD, Chun, YS, Ludmir, EB, Koay, EJ, Javle, M, Vauthey, JN, Tran Cao, HS. Defining the Role of Adjuvant Radiotherapy for Biliary Tract Cancers. Cancers 17(3), 2025. e-Pub 2025. PMID: 39941861.
15. Copling, S, Rooney, M, Das, P, Koay, EJ, Ludmir, EB, Minsky, B, Noticewala, SS, Smith, GL, Holliday, EB. Modest radiation dose escalation for early-stage anal cancer. Frontiers in Oncology 15, 2025. e-Pub 2025. PMID: 41179663.
16. Sherry, AD, Passy, AH, Abi Jaoude, J, Lin, TA, Kouzy, R, Msaouel, P, Ludmir, EB. Treatment group-specific inferences in Phase III Randomized Oncology Trials. Acta Oncologica 64:470-474, 2025. e-Pub 2025. PMID: 40126209.
17. Chung, CV, Nair, S, Khan, M, Nguyen, CI, Martin-Paulpeter, RM, Ludmir, EB, Court, LE, Niedzielski, JS. Novel volumetric modulated arc therapy approach for lattice radiation therapy for bulky liver tumors. Frontiers in Oncology 15, 2025. e-Pub 2025.
18. Dudzinski SO,, Cabanillas ME,, Hamidi S,, Marczyk VR,, Busaidy NL,, Dadu R,, Welsh J,, Hu MI,, Gunn GB,, Wang C,, Waguespack SG,, Phan J,, Beckham TH,, Chang JY,, Sherman SI,, Reddy JP,, Ying AK,, O'Reilly M,, Chen A,, Lee A,, Gandhi S,, Liao Z,, Ludmir EB,, Nguyen Q,, Lin SH,, Zafereo M,, Ning M,. Definitive Radiotherapy for Oligometastatic and Oligoprogressive Thyroid Cancer. JNCCN Journal of the National Comprehensive Cancer Network 23(1), 2025. e-Pub 2025. PMID: 39662038.
19. Sherry AD, Lin TA, McCaw ZR, Beck EJ, Kouzy R, Abi Jaoude J, Passy AH, Miller AM, Kupferman GS, Fuller CD, Thomas CR Jr, Koay EJ, Tang C, Msaouel P, Ludmir EB. Off-Protocol Radiation Therapy in Phase 3 Metastatic Solid Tumor Trials. Int J Radiat Oncol Biol Phys 120(5):1239-1244, 2024. e-Pub 2024. PMID: 39352322.
20. Corrigan KL, Andring LM, Das P, Pfennig C, Porter KB, Ludmir EB, Noticewala SS, Minsky BD, Smith GL, Koay EJ, Koong AC, Arzola A, Lee SJ, Nelms L, Holliday EB. Evaluating pre-consult patient education videos for patients with newly-diagnosed anal squamous cell carcinoma: Impact on patient comprehension, satisfaction and distress. Tech Innov Patient Support Radiat Oncol 32:100271, 2024. e-Pub 2024. PMID: 39403310.
21. Fang P, Noticewala SS, Wu SY, Gunther JR, Ludmir EB, Medeiros LJ, Strati P, Nair R, Nze C, Nastoupil LJ, Ahmed S, Castillo LM, Fayad L, Westin J, Neelapu S, Flowers C, Huen A, Iyer SP, Dabaja B, Pinnix CC. Early-Stage Extranodal NK/T-Cell Lymphoma, Nasal Type: A Role for Elective Nodal Irradiation?. Adv Radiat Oncol 9(12):101650, 2024. e-Pub 2024. PMID: 39553398.
22. Corrigan KL, Bankston ME, Holliday EB, Shaitelman SF, Lee A, Goodman CR, Fuller CD, Chino FL, Thomas CR, Jagsi R, Ludmir EB. Disease site specialization in the academic radiation oncology workforce: Evidence of gender differences. Int J Radiat Oncol Biol Phys 120(4):936-939, 2024. e-Pub 2024. PMID: 38897359.
23. Martin-Paulpeter RM, Jensen PJ, Perles LA, Sawakuchi GO, Das P, Koay EJ, Koong AC, Ludmir EB, Niedzielski JS, Beddar S. Daily Diagnostic Quality Computed Tomography-on-Rails (CTOR) Image Guidance for Abdominal Stereotactic Body Radiation Therapy (SBRT). Cancers (Basel) 16(22), 2024. e-Pub 2024. PMID: 39594725.
24. Tom MC, Komatineni S, Wang C, de Almeida RAA, Ghia AJ, Beckham TH, Perni S, McAleer MF, Swanson T, Yeboa DN, De BS, Rooney MK, Bishop AJ, Reddy JP, Yang Y, Ludmir EB, Zhang S, Amini B, Alvarez-Breckenridge C, North RY, Rhines LD, Li J, Tatsui CE. Spinal laser interstitial thermal therapy and radiotherapy for thoracic metastatic epidural spinal cord compression. J Neurooncol 170(2):289-296, 2024. e-Pub 2024. PMID: 39325339.
25. Chung CV, Khan MS, Olanrewaju A, Pham M, Nguyen QT, Patel T, Das P, O'Reilly MS, Reed VK, Jhingran A, Simonds H, Ludmir EB, Hoffman KE, Naidoo K, Parkes J, Aggarwal A, Mayo LL, Shah SJ, Tang C, Beadle BM, Wetter J, Walker G, Hughes S, Mullassery V, Skett S, Thomas C, Zhang L, Nguyen S, Mumme RP, Douglas RJ, Baroudi H, Court LE. Knowledge-based planning for fully automated radiation therapy treatment planning of 10 different cancer sites. Radiother Oncol 202:110609, 2024. e-Pub 2024. PMID: 39486482.
26. Reddy JP, Sherry AD, Fellman B, Liu S, Bathala T, Haymaker C, Cohen L, Smith BD, Ramirez D, Shaitelman SF, Chun SG, Medina-Rosales M, Teshome M, Brewster A, Barcenas CH, Reuben A, Ghia AJ, Ludmir EB, Weed D, Shah SJ, Mitchell MP, Woodward WA, Gomez DR, Tang C. Adding Metastasis-Directed Therapy to Standard-of-Care Systemic Therapy for Oligometastatic Breast Cancer (EXTEND): a Multicenter, Randomized Phase II Trial. Int J Radiat Oncol Biol Phys 121(4):885-893, 2024. e-Pub 2024. PMID: 39486645.
27. Sherry AD, Msaouel P, Kupferman GS, Lin TA, Abi Jaoude J, Kouzy R, McCaw ZR, Ludmir EB, van Zwet E. Evidenced-Based Prior for Estimating the Treatment Effect of Phase III Randomized Trials in Oncology. JCO Precis Oncol 8:e2400363, 2024. e-Pub 2024. PMID: 39348660.
28. De B, Dogra P, Zaid M, Elganainy D, Sun K, Amer AM, Wang C, Rooney MK, Chang E, Kang HC, Wang Z, Bhosale P, Odisio BC, Newhook TE, Tzeng CD, Cao HST, Chun YS, Vauthey JN, Lee SS, Kaseb A, Raghav K, Javle M, Minsky BD, Noticewala SS, Holliday EB, Smith GL, Koong AC, Das P, Cristini V, Ludmir EB, Koay EJ. Measurable imaging-based changes in enhancement of intrahepatic cholangiocarcinoma after radiotherapy reflect physical mechanisms of response. medRxiv, 2024. e-Pub 2024. PMID: 39314943.
29. Sherry AD, Passy AH, McCaw ZR, Abi Jaoude J, Lin TA, Kouzy R, Miller AM, Kupferman GS, Beck EJ, Msaouel P, Ludmir EB. Increasing Power in Phase III Oncology Trials With Multivariable Regression: An Empirical Assessment of 535 Primary End Point Analyses. JCO Clin Cancer Inform 8:e2400102, 2024. e-Pub 2024. PMID: 39213473.
30. Armbruster S, Ludmir EB, Wei LJ. Valid Analysis of Brain-Specific Progression-Free Survival. JAMA Oncol 10(8):1134-1135, 2024. e-Pub 2024. PMID: 38869861.
31. Sherry AD, Lin TA, McCaw ZR, Beck EJ, Kouzy R, Abi Jaoude J, Passy AH, Miller AM, Kupferman GS, Fuller CD, Thomas CR Jr, Koay EJ, Tang C, Msaouel P, Ludmir EB. Improving the clinical meaning of surrogate endpoints: An empirical assessment of clinical progression in phase III oncology trials. Int J Cancer 155(11):1939-1943, 2024. e-Pub 2024. PMID: 39138841.
32. Lin TA, McCaw ZR, Koong A, Lin C, Abi Jaoude J, Patel R, Kouzy R, El Alam MB, Sherry AD, Noticewala SS, Fuller CD, Thomas CR, Sun R, Lee JJ, Lin R, Yuan Y, Shyr Y, Meirson T, Ludmir EB. Proportional Hazards Violations in Phase 3 Cancer Clinical Trials: A Potential Source of Trial Misinterpretation. Clin Cancer Res 30(20):4791-4799, 2024. e-Pub 2024. PMID: 39133081.
33. Ludmir EB, Sherry AD, Fellman BM, Liu S, Bathala T, Haymaker C, Medina-Rosales MN, Reuben A, Holliday EB, Smith GL, Noticewala SS, Nicholas S, Price TR, Martin-Paulpeter RM, Perles LA, Lee SS, Lee MS, Smaglo BG, Huey RW, Willis J, Zhao D, Cohen L, Taniguchi CM, Koay EJ, Katz MHG, Wolff RA, Das P, Pant S, Koong AC, Tang C. Addition of Metastasis-Directed Therapy to Systemic Therapy for Oligometastatic Pancreatic Ductal Adenocarcinoma (EXTEND): A Multicenter, Randomized Phase II Trial. J Clin Oncol 42(32):JCO2400081, 2024. e-Pub 2024. PMID: 39102622.
34. Sherry AD, Lin TA, McCaw ZR, Ludmir EB. Interpretation of long-term survival data from MONARCH 3. Letter to the Editor regarding 'Abemaciclib plus a nonsteroidal aromatase inhibitor as initial therapy for HR+, HER2- advanced breast cancer: Final overall survival results of MONARCH 3' by M. P. Goetz et al. Ann Oncol 35(8):747-748, 2024. e-Pub 2024. PMID: 38838846.
35. Beck EJ, Sherry AD, Florez MA, Kouzy R, Abi Jaoude J, Lin TA, Miller AM, Passy AH, Kupferman GS, Patel RR, Chino F, Higbie VS, Parseghian CM, Overman MJ, Minsky BD, Thomas CR Jr, Tang C, Msaouel P, Ludmir EB. Secondary Endpoint Utilization and Publication Rate among Phase III Oncology Trials. Cancer Res Commun 4(8):2183-2188, 2024. e-Pub 2024. PMID: 39099199.
36. Yousef M, Hurd MW, Yousef A, Ludmir EB, Pillai AB, Peterson J, Koay EJ, Albarouki S, Tzeng CW, Snyder R, Katz MHG, Wang H, Overman MJ, Maitra A, Pant S, Smaglo BG, Wolff RA, Yao J, Shen JP, Zhao D. Clinical and molecular characteristics of patients with brain metastasis secondary to pancreatic ductal adenocarcinoma. Oncologist 30(1), 2024. e-Pub 2024. PMID: 39014543.
37. Sherry AD, Msaouel P, Kouzy R, Abi Jaoude J, Lin TA, Taniguchi CM, Fuller CD, Minsky B, Ludmir EB. Lost in the plot: missing visual elements in Kaplan-Meier plots of phase III oncology trials. Oncologist 29(7):547-550, 2024. e-Pub 2024. PMID: 38824414.
38. Hsu EJ, Lin TA, Dabush DR, McCaw Z, Koong A, Lin C, Abi Jaoude J, Patel R, Kouzy R, El Alam MB, Noticewala S, Yang Y, Sherry AD, Fuller CD, Thomas CR, Tang C, Msaouel P, Das P, Huang B, Tian L, Sun R, Lee JJ, Meirson T, Ludmir EB. Association of differential censoring with survival and suboptimal control arms among oncology clinical trials. J Natl Cancer Inst 116(6):990-994, 2024. e-Pub 2024. PMID: 38331394.
39. Kouzy R, El Alam MB, Corrigan KL, Lalani HS, Ludmir EB. Patient-Level Savings on Generic Drugs Through the Mark Cuban Cost Plus Drug Company. JAMA Health Forum 5(6):e241468, 2024. e-Pub 2024. PMID: 38874962.
40. Shi C,, De BS,, Tran Cao HS,, Liu S,, Florez MA,, Kouzy R,, Grippin A,, Katz MH,, Tzeng CD,, Ikoma N,, Kim M,, Lee S,, Willis JA,, Noticewala SS,, Minsky B,, Smith GL,, Holliday EB,, Taniguchi C,, Koong A,, Das P,, Ludmir EB,, Koay EJ,. Escalated-dose radiotherapy for unresected locally advanced pancreatic cancer. Cancer medicine 13(12), 2024. e-Pub 2024. PMID: 38923407.
41. Deboever N, Mitchell KG, Farooqi A, Ludmir EB, Hofstetter WL, Mehran RJ, Rajaram R, Rice DC, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Heymach JV, Gomez DR, Gandhi SJ, Antonoff MB. Perioperative and oncologic outcomes of pulmonary resection for synchronous oligometastatic non-small cell lung cancer: Evidence for surgery in advanced disease. J Thorac Cardiovasc Surg 167(6):1929-1935.e2, 2024. e-Pub 2024. PMID: 37619884.
42. Taparra K, Benavente R, Shih JJ, Gimmen MY, Tominez P, Kekumano KE, Pineda E, Halualani G, Cakobau H, Ludmir EB, Deville C, Peppercorn J, Gomez SL, Bosserman L, Chino F, Patel MI, Shah C. Race and Ethnicity Representation in Phase 2/3 Oncology Clinical Trial Publications: A Systematic Review. JAMA Health Forum 5(6):e241388, 2024. e-Pub 2024. PMID: 38848090.
43. Averbuch I, Moore A, Ludmir EB, Markel G, Meirson T. Assessing the effect of metastasis-directed therapy in oligometastatic disease using the restricted mean survival time. Br J Cancer 130(12):1929-1935, 2024. e-Pub 2024. PMID: 38710837.
44. Rooney MK, Niedzielski JS, Salazar RM, Arzola A, Das P, Koay EJ, Koong A, Ludmir EB, Minsky BD, Noticewala S, Smith GL, Taniguchi C, Holliday EB. Long-Term Patient-Reported Dyspareunia After Definitive Chemoradiation for Anal Cancer: Using the Anterior Vaginal Wall as an Organ-at-Risk to Define an Actionable Dosimetric Goal. Adv Radiat Oncol 9(5):101449, 2024. e-Pub 2024. PMID: 38550361.
45. Chang E, Wong FCL, Chasen BA, Erwin WD, Das P, Holliday EB, Koong AC, Ludmir EB, Minsky BD, Noticewala SS, Smith GL, Taniguchi CM, Rodriguez MJ, Beddar S, Martin-Paulpeter RM, Niedzielski JS, Sawakuchi GO, Schueler E, Perles LA, Xiao L, Szklaruk J, Park PC, Dasari AN, Kaseb AO, Kee BK, Lee SS, Overman MJ, Willis JA, Wolff RA, Tzeng CD, Vauthey JN, Koay EJ. Phase I trial of single-photon emission computed tomography-guided liver-directed radiotherapy for patients with low functional liver volume. JNCI Cancer Spectr 8(3), 2024. e-Pub 2024. PMID: 38730548.
46. Sherry AD,, Msaouel P,, Lin TA,, Abi Jaoude J,, Kouzy R,, Beck E,J, Miller AM,, Passy AH,, Kupferman GS,, Koay EJ,, Fuller C,, Thomas CR,, McCaw ZR,, Ludmir EB,. Postprogression therapy and confounding for the estimated treatment effect on overall survival in phase III oncology trials. BMJ Oncology 3(1), 2024. e-Pub 2024. PMID: 39886131.
47. Huang K, Chung C, Ludmir EB, Zhang L, Owens CA, Vega JG, Duryea J, Zhao Y, Chen X, Fuentes D, Cardenas CE, Briere TM, Beddar S, Court LE, Das P. Automatic end-to-end VMAT treatment planning for rectal cancers. J Appl Clin Med Phys 25(4):e14259, 2024. e-Pub 2024. PMID: 38317597.
48. Sherry AD, Hahn AW, McCaw ZR, Abi Jaoude J, Kouzy R, Lin TA, Minsky B, Fuller CD, Meirson T, Msaouel P, Ludmir EB. Differential Treatment Effects of Subgroup Analyses in Phase 3 Oncology Trials From 2004 to 2020. JAMA Netw Open 7(3):e243379, 2024. e-Pub 2024. PMID: 38546648.
49. Damron EP, McDonald J, Rooney MK, Das P, Ludmir EB, Minsky BD, Messick C, Chang GJ, Morris VK, Holliday EB. Salvage Treatment of Recurrent or Persistent Anal Squamous Cell Carcinoma: The Role of Multi-modality Therapy. Clin Colorectal Cancer 23(1):85-94, 2024. e-Pub 2024. PMID: 38216367.
50. Wu TC, Smith CP, Li JS, Burton J, Jackson NJ, Tao R, Ludmir EB, Raldow AC. A systematic review and meta-analysis of pathologic complete response rates for patients with cholangiocarcinoma treated on liver transplant protocols. J Surg Oncol 129(3):574-583, 2024. e-Pub 2024. PMID: 37986552.
51. Ludmir EB, Hoffman KE, Jhingran A, Kouzy R, Ip MP, Sturdevant L, Ning MS, Minsky BD, McAleer MF, Chronowski GM, Arzu IY, Reed VK, Garg AK, Roberts T, Eastwick GA, Olson MR, Selek U, Gabel M, Koong AC, Kupferman ME, Kuban DA. Implementation and Efficacy of a Large-Scale Radiation Oncology Case-Based Peer-Review Quality Program across a Multinational Cancer Network. Pract Radiat Oncol 14(3):e173-e179, 2024. e-Pub 2024. PMID: 38176466.
52. Arzola A, Chang E, Rooney MK, Corrigan K, Das P, Ludmir EB, Koay EJ, Minsky BD, Smith GL, Messick C, Morris VK, Nebgen D, Crane CH, Holliday EB. Daily vaginal dilator use during radiation for women with squamous cell carcinoma of the anus: vaginal wall dosimetry and patient-reported sexual function. Pract Radiat Oncol 14(2):e105-e116, 2024. e-Pub 2024. PMID: 37898354.
53. Waldhorn I, Bomze D, Ben-Aharon I, Schlosser S, Markel G, Ludmir EB, Meirson T. Gender Gap in Leadership of Clinical Trials. JAMA Intern Med 183(12):1406-1408, 2023. e-Pub 2023. PMID: 37902723.
54. Rooney MK, Pasli M, Chang GJ, Das P, Koay EJ, Koong AC, Ludmir EB, Minsky BD, Noticewala SS, Peacock O, Smith GL, Holliday EB. Patient-Reported Sexual Function, Bladder Function and Quality of Life for Patients with Low Rectal Cancers with or without a Permanent Ostomy. Cancers (Basel) 16(1), 2023. e-Pub 2023. PMID: 38201580.
55. Taniguchi CM, Frakes JM, Aguilera TA, Palta M, Czito B, Bhutani MS, Colbert LE, Abi Jaoude J, Bernard V, Pant S, Tzeng CD, Kim DW, Malafa M, Costello J, Mathew G, Rebueno N, Koay EJ, Das P, Ludmir EB, Katz MHG, Wolff RA, Beddar S, Sawakuchi GO, Moningi S, Slack Tidwell RS, Yuan Y, Thall PF, Beardsley RA, Holmlund J, Herman JM, Hoffe SE. Stereotactic body radiotherapy with or without selective dismutase mimetic in pancreatic adenocarcinoma: an adaptive, randomised, double-blind, placebo-controlled, phase 1b/2 trial. Lancet Oncol 24(12):1387-1398, 2023. e-Pub 2023. PMID: 38039992.
56. Sherry AD, Corrigan KL, Kouzy R, Jaoude JA, Yang Y, Patel RR, Totten DJ, Newman NB, Das P, Taniguchi C, Minsky B, Snyder RA, Fuller CD, Ludmir E. Prevalence, trends, and characteristics of trials investigating local therapy in contemporary phase 3 clinical cancer research. Cancer 129(21):3430-3438, 2023. e-Pub 2023. PMID: 37382235.
57. Sherry AD, Msaouel P, McCaw ZR, Abi Jaoude J, Hsu EJ, Kouzy R, Patel R, Yang Y, Lin TA, Taniguchi CM, Rödel C, Fokas E, Tang C, Fuller CD, Minsky B, Meirson T, Sun R, Ludmir EB. Prevalence and implications of significance testing for baseline covariate imbalance in randomised cancer clinical trials: The Table 1 Fallacy. Eur J Cancer 194:113357, 2023. e-Pub 2023. PMID: 37827064.
58. McDonald MF, Prather LL, Helfer CR, Ludmir EB, Echeverria AE, Yust-Katz S, Patel AJ, Deneen B, Rao G, Jalali A, Dhar SU, Amos CI, Mandel JJ. Prevalence of pathogenic germline variants in adult-type diffuse glioma. Neurooncol Pract 10(5):482-490, 2023. e-Pub 2023. PMID: 37720399.
59. De BS,, Upadhyay R,, Liao K,, Kumala T,, Shi C,, Dodoo G,, Abi Jaoude J,, Corrigan KL,, Manzar GS,, Marqueen KE,, Bernard V,, Lee SS,, Raghav KS,, Vauthey JN,, Tzeng CW,, Tran Cao HS,, Lee G,, Wo JY,, Hong TS,, Crane C,, Minsky B,, Smith GL,, Holliday EB,, Taniguchi C,, Koong A,, Das P,, Javle M,, Ludmir EB,, Koay EJ,. Definitive Liver Radiotherapy for Intrahepatic Cholangiocarcinoma with Extrahepatic Metastases. Liver Cancer 12(3):198-208, 2023. e-Pub 2023. PMID: 37593365.
60. Wang X, McCaw ZR, Tian L, Stinchcombe TE, Vokes E, Ludmir EB, Wei LJ. Using a Clinically Interpretable End Point Composed of Multiple Outcomes to Evaluate Totality of Treatment Effect in Comparative Oncology Studies. JAMA Netw Open 6(6):e2319055, 2023. e-Pub 2023. PMID: 37342044.
61. Rooney MK, De B, Corrigan K, Smith GL, Taniguchi C, Minsky BD, Ludmir EB, Koay EJ, Das P, Koong AC, Peacock O, Chang G, You YN, Morris VK, Nogueras-González G, Holliday EB. Patient-reported Bowel Function and Bowel-related Quality of Life After Pelvic Radiation for Rectal Adenocarcinoma: The Impact of Radiation Fractionation and Surgical Resection. Clin Colorectal Cancer 22(2):211-221, 2023. e-Pub 2023. PMID: 36878805.
62. Lin TA, Das A, McCaw Z, Ludmir EB. Determining the Efficacy of Pembrolizumab in Patients With Previously Treated Advanced Hepatocellular Carcinoma. J Clin Oncol 41(16):JCO2300072, 2023. e-Pub 2023. PMID: 37015029.
63. Florez MA, Jaoude JA, Patel RR, Kouzy R, Lin TA, De B, Beck EJ, Taniguchi CM, Minsky BD, Fuller CD, Lee JJ, Kupferman M, Raghav KP, Overman MJ, Thomas CR, Ludmir EB. Incidence of Primary End Point Changes Among Active Cancer Phase 3 Randomized Clinical Trials. JAMA Netw Open 6(5):e2313819, 2023. e-Pub 2023. PMID: 37195664.
64. Das A, Lin TA, Lin C, Meirson T, McCaw ZR, Tian L, Ludmir EB. Assessment of Median and Mean Survival Time in Cancer Clinical Trials. JAMA Netw Open 6(4), 2023. e-Pub 2023. PMID: 37010873.
65. Dodoo GN, De B, Lee SS, Abi Jaoude J, Vauthey JN, Tzeng CD, Tran Cao HS, Katlowitz KA, Mandel JJ, Beckham TH, Minsky BD, Smith GL, Holliday EB, Koong AC, Das P, Taniguchi CM, Javle M, Koay EJ, Ludmir EB. Brain Metastases from Biliary Tract Cancer: Case Series and Clinicogenomic Analysis. Oncologist 28(4):327-332, 2023. e-Pub 2023. PMID: 36715178.
66. Koong A, Gardner UG, Burton J, Stewart C, Thompson P, Fuller CD, Ludmir EB, Rooney MK. Factors Associated With Open Access Publishing Costs in Oncology Journals: Cross-sectional Observational Study. JMIR Form Res 7:e44633, 2023. e-Pub 2023. PMID: 36927553.
67. Newhook TE, Vreeland TJ, Griffin JF, Tidwell RSS, Prakash LR, Koay EJ, Ludmir EB, Smaglo BG, Pant S, Overman M, Wolff RA, Ikoma N, Maxwell J, Kim MP, Lee JE, Katz MHG, Tzeng CD. Prognosis Associated With CA19-9 Response Dynamics and Normalization During Neoadjuvant Therapy in Resected Pancreatic Adenocarcinoma. Ann Surg 277(3):484-490, 2023. e-Pub 2023. PMID: 36649067.
68. Hernandez S, Das P, Holliday EB, Shen L, Lu W, Johnson B, Messick CA, Taniguchi CM, Skibber J, Ludmir EB, You YN, Smith GL, Bednarski B, Kostousov L, Koay EJ, Minsky BD, Tillman M, Portier S, Eng C, Koong AC, Chang GJ, Foo WC, Wang J, Soto LS, Morris VK. Differential Spatial Gene and Protein Expression Associated with Recurrence Following Chemoradiation for Localized Anal Squamous Cell Cancer. Cancers (Basel) 15(6), 2023. e-Pub 2023. PMID: 36980587.
69. McCaw ZR, Ludmir EB, Wei LJ. Assessing the Clinical Utility of Oral Paclitaxel Plus Encequidar Versus Intravenous Paclitaxel in Patients With Metastatic Breast Cancer. J Clin Oncol 41(6):JCO2201759, 2023. e-Pub 2023. PMID: 36331242.
70. Rooney MK,, Sharifi B,, Ludmir EB,, Fuller C,, Warner J,. Factors Associated With Altmetric Attention Scores for Randomized Phase III Cancer Clinical Trials. JCO Clinical Cancer Informatics 7, 2023. e-Pub 2023. PMID: 37552823.
71. De B, Farooqi AS, Mitchell KG, Ludmir EB, Lewis J, Rinsurongkawong W, Rinsurongkawong V, Lee JJ, Swisher SG, Gibbons DL, Zhang J, Le X, Elamin YY, Gomez DR, Ning MS, Lin SH, Liao Z, Chang JY, Vaporciyan AA, Heymach JV, Antonoff MB, Gandhi SJ. Benchmarking Outcomes for Molecularly Characterized Synchronous Oligometastatic Non-Small-Cell Lung Cancer Reveals EGFR Mutations to Be Associated With Longer Overall Survival. JCO Precis Oncol 7:e2200540, 2023. e-Pub 2023. PMID: 36716413.
72. Lin TA, Wei LJ, Ludmir EB. Radiotherapy Alone vs Radiotherapy With Concurrent Chemoradiotherapy and Survival of Patients With Low-Risk Nasopharyngeal Carcinoma. JAMA 329(3):261, 2023. e-Pub 2023. PMID: 36648473.
73. Garner WB, Smith BD, Ludmir EB, Wakefield DV, Shabason J, Williams GR, Martin MY, Wang Y, Ballo MT, VanderWalde NA. Predicting future cancer incidence by age, race, ethnicity, and sex. J Geriatr Oncol 14(1):101393, 2023. e-Pub 2023. PMID: 36692964.
74. De B, Florez MA, Ludmir EB, Maor MH, McGovern SL, McAleer MF, Grosshans DR, Chang EL, Mahajan A, Paulino AC. Late Effects of Craniospinal Irradiation Using Electron Spinal Fields for Pediatric Cancer Patients. Int J Radiat Oncol Biol Phys 115(1):164-173, 2023. e-Pub 2023. PMID: 35716848.
75. Yang Y, Jayaraj S, Ludmir E, Roberts K. Text Classification of Cancer Clinical Trial Eligibility Criteria. AMIA Annu Symp Proc 2023:1304-1313, 2023. e-Pub 2023. PMID: 38222417.
76. Rhee DJ, Beddar S, Jaoude JA, Sawakuchi G, Martin R, Perles L, Yu C, He Y, Court LE, Ludmir EB, Koong AC, Das P, Koay EJ, Taniguichi C, Niedzielski JS. Dose Escalation for Pancreas SBRT: Potential and Limitations of using Daily Online Adaptive Radiation Therapy and an Iterative Isotoxicity Automated Planning Approach. Adv Radiat Oncol 8(4):101164, 2023. e-Pub 2023. PMID: 36798731.
77. Corrigan KL, Kouzy R, Jaoude JA, Patel RR, Layman RM, Giordano SH, Woodward WA, Smith BD, Shaitelman SF, Ludmir EB. Inclusion of premenopausal women in breast cancer clinical trials. Breast 66:204-207, 2022. e-Pub 2022. PMID: 36327626.
78. Koay EJ, Zaid M, Aliru M, Bagereka P, Van Wieren A, Rodriguez MJ, Jacobson G, Wolff RA, Overman M, Varadhachary G, Pant S, Wang H, Tzeng CW, Ikoma N, Kim M, Lee JE, Katz MH, Tamm E, Bhosale P, Taniguchi CM, Holliday EB, Smith GL, Ludmir EB, Minsky BD, Crane CH, Koong AC, Das P, Wang X, Javle M, Krishnan S. Nab-Paclitaxel, Capecitabine, and Radiation Therapy Following Induction Chemotherapy in Treating Patients with Locally Advanced and Borderline Resectable Pancreatic Cancer: Phase I Trial and Imaging-based Biomarker Validation. Int J Radiat Oncol Biol Phys 114(3):444-453, 2022. e-Pub 2022. PMID: 35863672.
79. Yu C, Anakwenze CP, Zhao Y, Martin RM, Ludmir EB, S Niedzielski J, Qureshi A, Das P, Holliday EB, Raldow AC, Nguyen CM, Mumme RP, Netherton TJ, Rhee DJ, Gay SS, Yang J, Court LE, Cardenas CE. Multi-organ segmentation of abdominal structures from non-contrast and contrast enhanced CT images. Sci Rep 12(1):19093, 2022. e-Pub 2022. PMID: 36351987.
80. Owens CA, Rigaud B, Ludmir EB, Gupta AC, Shrestha S, Paulino AC, Smith SA, Peterson CB, Kry SF, Lee C, Henderson TO, Armstrong GT, Brock KK, Howell RM. Development and validation of a population-based anatomical colorectal model for radiation dosimetry in late effects studies of survivors of childhood cancer. Radiother Oncol 176:118-126, 2022. e-Pub 2022. PMID: 36063983.
81. Huang B, Sun R, Claggett B, Tian L, Ludmir EB, Wei LJ. Handling Informative Premature Treatment or Study Discontinuation for Assessing Between-Group Differences in a Comparative Oncology Trial. JAMA Oncol 8(10):1502-1503, 2022. e-Pub 2022. PMID: 35980612.
82. Corrigan KL, Rooney MK, De B, Ludmir EB, Das P, Smith GL, Taniguchi C, Minsky BD, Koay EJ, Koong A, Morris VK, Messick CA, Nogueras-Gonzalez G, Holliday EB. Patient-reported sexual function in long-term survivors of anal cancer treated with definitive intensity-modulated radiotherapy and concurrent chemotherapy. Pract Radiat Oncol 12(5):e397-e405, 2022. e-Pub 2022. PMID: 35643295.
83. De B, Corrigan KL, Rooney MK, Ludmir EB, Das P, Smith GL, Taniguchi CM, Minsky BD, Koay EJ, Koong A, Morris VK, Messick CA, You YN, Chang GJ, Westney OL, Nogueras Gonzalez GM, Holliday EB. Patient-reported bowel and urinary function in long-term survivors of squamous cell carcinoma of the anus treated with definitive intensity-modulated radiotherapy and concurrent chemotherapy. Int J Radiat Oncol Biol Phys 114(1):78-88, 2022. e-Pub 2022. PMID: 35589011.
84. Khan Z, Rooney MK, Das P, Ludmir EB, Koay EJ, Smith GL, Taniguchi C, Minsky BD, Koong AC, Sawakuchi G, Beddar S, Martin RM, Rodriguez-Bigas M, Peacock O, Chang G, Holliday EB. Intraoperative Radiation After Pelvic Short Course Radiation-Based Total Neoadjuvant Therapy for Patients With Rectal Adenocarcinoma at High Risk for Local Recurrence. Clin Colorectal Cancer 21(3):204-211, 2022. e-Pub 2022. PMID: 35125321.
85. Diefenhardt M, Martin D, Ludmir EB, Fleischmann M, Hofheinz RD, Ghadimi M, Kosmala R, Polat B, Friede T, Minsky BD, Rödel C, Fokas E. Development and Validation of a Predictive Model for Toxicity of Neoadjuvant Chemoradiotherapy in Rectal Cancer in the CAO/ARO/AIO-04 Phase III Trial. Cancers (Basel) 14(18), 2022. e-Pub 2022. PMID: 36139585.
86. Chapman BV, Rooney MK, Ludmir EB, De La Cruz D, Salcedo A, Pinnix CC, Das P, Jagsi R, Thomas CR, Holliday EB. Linguistic Biases in Letters of Recommendation for Radiation Oncology Residency Applicants from 2015 to 2019. J Cancer Educ 37(4):965-972, 2022. e-Pub 2022. PMID: 33111188.
87. Moningi S, Lei X, Fang P, Taniguchi CM, Holliday EB, Koay EJ, Koong AC, Ludmir EB, Minsky BD, Das P, Giordano SH, Smith GL. Contemporary use and outcomes of radiation and chemotherapy for unresectable pancreatic cancer. Clin Transl Radiat Oncol 35:9-16, 2022. e-Pub 2022. PMID: 35510142.
88. Corrigan KL, De B, Rooney MK, Ludmir EB, Das P, Smith GL, Taniguchi CM, Minsky BD, Koay EJ, Koong AC, Holliday EB. Patient-Reported Outcomes After Chemoradiation in Patients With Anal Cancer: A Qualitative Analysis. Adv Radiat Oncol 7(4):100986, 2022. e-Pub 2022. PMID: 35662810.
89. De B, Tran Cao HS, Vauthey JN, Manzar GS, Corrigan KL, Raghav KPS, Lee SS, Tzeng CD, Minsky BD, Smith GL, Holliday EB, Taniguchi CM, Koong AC, Das P, Javle M, Ludmir EB, Koay EJ. Ablative liver radiotherapy for unresected intrahepatic cholangiocarcinoma: Patterns of care and survival in the United States. Cancer 128(13):2529-2539, 2022. e-Pub 2022. PMID: 35417569.
90. Manzar GS, De BS, Abana CO, Lee SS, Javle M, Kaseb AO, Vauthey JN, Tran Cao HS, Koong AC, Smith GL, Taniguchi CM, Holliday EB, Das P, Koay EJ, Ludmir EB. Outcomes and Toxicities of Modern Combined Modality Therapy with Atezolizumab Plus Bevacizumab and Radiation Therapy for Hepatocellular Carcinoma. Cancers (Basel) 14(8), 2022. e-Pub 2022. PMID: 35454808.
91. Kouzy R, Abi Jaoude J, Minsky BD, Das P, Koong AC, Subbiah IM, Ludmir EB, Taniguchi CM. Gastrointestinal malignancies and supportive care trials: a snapshot of the last two decades. BMJ Support Palliat Care 12(1):42-45, 2022. e-Pub 2022. PMID: 32943466.
92. Taku N, Yi-Qian YN, Chang GJ, Ludmir EB, Raghav KPS, Rodriguez-Bigas MA, Holliday EB, Smith GL, Minsky BD, Overman MJ, Messick C, Boyce-Fappiano D, Koong AC, Skibber JM, Koay EJ, Dasari A, Taniguchi CM, Bednarski BK, Morris VK, Kopetz S, Das P. Benchmarking Outcomes for Definitive Treatment of Young-Onset, Locally Advanced Rectal Cancer. Clin Colorectal Cancer 21(1):e28-e37, 2022. e-Pub 2022. PMID: 34794903.
93. Antonoff MB, Feldman HA, Mitchell KG, Farooqi A, Ludmir EB, Hofstetter WL, Mehran RJ, Rajaram R, Rice DC, Sepesi B, Swisher SG, Walsh GL, Gandhi S, Gomez DR, Vaporciyan AA. Surgical Complexity of Pulmonary Resections Performed for Oligometastatic NSCLC. JTO Clin Res Rep 3(3):100288, 2022. e-Pub 2022. PMID: 35252897.
94. Tchelebi LT, Eng C, Messick CA, Hong TS, Ludmir EB, Kachnic LA, Zaorsky NG. Current treatment and future directions in the management of anal cancer. CA Cancer J Clin 72(2):183-195, 2022. e-Pub 2022. PMID: 34847242.
95. Patel RR, Parisi R, Verma V, Kouzy R, Abi Jaoude J, Lin TA, Fuller CD, VanderWalde NA, Jagsi R, Smith BD, Guadagnolo BA, Thomas CR, Ludmir EB. Association between Prior Malignancy Exclusion Criteria and Age Disparities in Cancer Clinical Trials. Cancers (Basel) 14(4), 2022. e-Pub 2022. PMID: 35205795.
96. Holliday EB,, Morris VK,, Johnson B,, Eng C,, Ludmir EB,, Das P,, Minsky B,, Taniguchi C,, Smith GL,, Koay EJ,, Koong A,, Delclos ME,, Skibber JM,, Rodriguez-Bigas MA,, You YN,, Bednarski BK,, Tillman MM,, Chang GJ,, Jennings K,, Messick C,. Definitive Intensity-Modulated Chemoradiation for Anal Squamous Cell Carcinoma. Oncologist 27(1):40-47, 2022. e-Pub 2022. PMID: 35305097.
97. Bagley AF, Ludmir EB, Maitra A, Minsky BD, Li Smith G, Das P, Koong AC, Holliday EB, Taniguchi CM, Katz MHG, Tamm EP, Wolff RA, Overman MJ, Patel S, Kim MP, Tzeng CD, Ikoma N, Bhutani MS, Koay EJ. NBTXR3, a first-in-class radioenhancer for pancreatic ductal adenocarcinoma: Report of first patient experience. Clin Transl Radiat Oncol 33:66-69, 2022. e-Pub 2022. PMID: 35097226.
98. Fokas E, Appelt A, Glynne-Jones R, Beets G, Perez R, Garcia-Aguilar J, Rullier E, Joshua Smith J, Marijnen C, Peters FP, van der Valk M, Beets-Tan R, Myint AS, Gerard JP, Bach SP, Ghadimi M, Hofheinz RD, Bujko K, Gani C, Haustermans K, Minsky BD, Ludmir EB, West NP, Gambacorta MA, Valentini V, Buyse M, Renehan AG, Gilbert A, Sebag-Montefiore D, Rödel C. International consensus recommendations on key outcome measures for organ preservation after (chemo)radiotherapy in patients with rectal cancer. Nat Rev Clin Oncol 18(12):805-816, 2021. e-Pub 2021. PMID: 34349247.
99. Rooney MK, Nesbit EG, Holliday EB, Jagsi R, Fuller CD, Ludmir EB, Sachdev S. Trends in Publication Speed of Radiation Oncology Research from 2010 to 2019. Adv Radiat Oncol 7(2):100863, 2021. e-Pub 2021. PMID: 35036635.
100. Niedzielski JS, Liu Y, Ng SSW, Martin RM, Perles LA, Beddar S, Rebueno N, Koay EJ, Taniguchi CM, Holliday EB, Das P, Smith GL, Minsky BD, Ludmir EB, Herman JM, Koong A, Sawakuchi GO. Dosimetric uncertainties resulting from interfractional anatomic variations for patients receiving pancreas stereotactic body radiation therapy and cone-beam CT image guidance. Int J Radiat Oncol Biol Phys 111(5):1298-1309, 2021. e-Pub 2021. PMID: 34400267.
101. De B, Abu-Gheida I, Patel A, Ng SSW, Zaid M, Thunshelle CP, Elganainy D, Corrigan KL, Rooney MK, Javle M, Raghav K, Lee SS, Vauthey JN, Tzeng CD, Tran Cao HS, Ludmir EB, Minsky BD, Smith GL, Holliday EB, Taniguchi CM, Koong AC, Das P, Koay EJ. Benchmarking Outcomes after Ablative Radiotherapy for Molecularly Characterized Intrahepatic Cholangiocarcinoma. J Pers Med 11(12), 2021. e-Pub 2021. PMID: 34945742.
102. Abi Jaoude J, Thunshelle CP, Kouzy R, Nguyen ND, Lin D, Prakash L, Bumanlag IM, Noticewala SS, Niedzielski JS, Beddar S, Ludmir EB, Holliday EB, Das P, Minsky BD, Herman JM, Katz M, Koong AC, Koay EJ, Taniguchi CM. Stereotactic Versus Conventional Radiation Therapy for Patients With Pancreatic Cancer in the Modern Era. Adv Radiat Oncol 6(6):100763, 2021. e-Pub 2021. PMID: 34934858.
103. Metzger AL, Kusi Appiah A, Wright CM, Jairam V, Amini A, Park HS, Welsh JW, Thomas CR, Verma V, Ludmir EB. Financial Relationships Between Industry and Principal Investigators of United States Cooperative Group Randomized Cancer Clinical Trials. Int J Cancer 149(9):1683-1690, 2021. e-Pub 2021. PMID: 34173669.
104. Corrigan KL, Kry S, Howell RM, Kouzy R, Jaoude JA, Patel RR, Jhingran A, Taniguchi C, Koong AC, McAleer MF, Nitsch P, Rödel C, Fokas E, Minsky BD, Das P, Fuller CD, Ludmir EB. The radiotherapy quality assurance gap among phase III cancer clinical trials. Radiother Oncol 166:51-57, 2021. e-Pub 2021. PMID: 34838891.
105. Diefenhardt M, Ludmir EB, Hofheinz RD, Ghadimi M, Minsky BD, Fleischmann M, Fokas E, Rödel C. Impact of body-mass index on treatment and outcome in locally advanced rectal cancer: A secondary, post-hoc analysis of the CAO/ARO/AIO-04 randomized phase III trial. Radiother Oncol 164:223-231, 2021. e-Pub 2021. PMID: 34619239.
106. Farooqi A, Ludmir EB, Mitchell KG, Antonoff MB, Tang C, Lee P, Chang J, Elamin Y, Gomez DR, Gandhi SJ. Increased biologically effective dose (BED) to the primary tumor is associated with improved survival in patients with oligometastatic NSCLC. Radiother Oncol 163:114-118, 2021. e-Pub 2021. PMID: 34419505.
107. Paulino AC, Ludmir EB, Grosshans DR, Su JM, McGovern SL, Okcu MF, McAleer MF, Baxter PA, Mahajan A, Chintagumpala MM. Overall survival and secondary malignant neoplasms in children receiving passively scattered proton or photon craniospinal irradiation for medulloblastoma. Cancer 127(20):3865-3871, 2021. e-Pub 2021. PMID: 34254296.
108. De B, Ludmir EB, Messick CA, Cagley MC, Morris VK, Das P, Minsky BD, Taniguchi CM, Smith GL, Koay EJ, Koong AC, Mohan R, Holliday EB. Prognostic impact of lymphopenia and neutrophil-lymphocyte ratio for patients with anal squamous cell carcinoma. J Gastrointest Oncol 12(5):2412-2422, 2021. e-Pub 2021. PMID: 34790402.
109. Christopherson KM, Das P, Berlind C, Lindsay WD, Ahern C, Smith BD, Subbiah I, Koay EJ, Koong AC, Holliday EB, Ludmir EB, Minsky B, Taniguchi C, Smith GL. A Machine Learning Model Approach to Risk-Stratify Gastrointestinal (GI) Cancer Patients for Hospitalization and Mortality Outcomes. Int J Radiat Oncol Biol Phys 111(1):135-142, 2021. e-Pub 2021. PMID: 33933480.
110. Abi Jaoude J, Kouzy R, Rooney M, Thompson P, Patel R, Turner MC, Ghabach M, Fuller CD, Minsky BD, Taniguchi CM, Ludmir EB. Impact factor and citation metrics in phase III cancer trials. Oncotarget 12(18):1780-1786, 2021. e-Pub 2021. PMID: 34504650.
111. Gardner UG, Thompson PS, Burton J, Stewart C, Fuller CD, Rooney MK, Ludmir EB. Article Processing Charge Waiver Policies as a Barrier to Oncology Scholarship in Low- and Lower-Middle-Income Countries. JCO Glob Oncol 7(7):1413-1417, 2021. e-Pub 2021. PMID: 34554813.
112. Mandel JJ, Youssef M, Yust-Katz S, Patel AJ, Jalali A, Li Z, Wu J, Ludmir EB, de Groot JF. IDH mutation status and the development of venous thromboembolism in astrocytoma patients. J Neurol Sci 427:117538, 2021. e-Pub 2021. PMID: 34146775.
113. Hanania AN, Paulino AC, Ludmir EB, Shah VS, Su JM, McGovern SL, Baxter PA, McAleer MF, Grosshans DR, Okcu MF, Chintagumpala MM. Early radiotherapy preserves vision in sporadic optic pathway glioma. Cancer 127(13):2358-2367, 2021. e-Pub 2021. PMID: 33739455.
114. Augustyn A, Medeiros LJ, Ludmir EB, Gunther J, Fang P, Li S, Ok CY, Bankston ME, Verma V, Pasalic D, Ahmed S, Nastoupil LJ, Westin JR, Strati P, Neelapu SS, Nair R, Steiner RE, Iyer SP, Rodriguez A, Fayad LE, Flowers CR, Dabaja BS, Pinnix CC. The impact of cell-of-origin, MYC/Bcl-2 dual expression and MYC rearrangement on disease relapse among early stage diffuse large B-cell lymphoma patients treated with combined modality therapy. Leuk Lymphoma 62(6):1361-1369, 2021. e-Pub 2021. PMID: 33480830.
115. Abi Jaoude J, Kouzy R, Ghabach M, Patel R, Pasalic D, Ghossain E, Miller AB, Lin TA, Verma V, Fuller CD, Subbiah V, Minsky BD, Ludmir EB, Taniguchi CM. Food and Drug Administration approvals in phase 3 Cancer clinical trials. BMC Cancer 21(1):695, 2021. e-Pub 2021. PMID: 34118915.
116. McCaw ZR, Ludmir EB, Wei LJ. Quantifying the Long-term Survival Benefit of Pembrolizumab for Patients With Advanced Gastric Cancer. JAMA Oncol 7(4):632-633, 2021. e-Pub 2021. PMID: 33538772.
117. Mitchell KG, Farooqi A, Ludmir EB, Corsini EM, Sepesi B, Gomez DR, Antonoff MB, Group MD. Pulmonary resection is associated with long-term survival and should remain a therapeutic option in oligometastatic lung cancer. J Thorac Cardiovasc Surg 161(4):1497-1504.e2, 2021. e-Pub 2021. PMID: 32331820.
118. Buszek SM, Ludmir EB, Grosshans DR, McAleer MF, McGovern SL, Harrison DJ, Okcu MF, Chintagumpala MM, Mahajan A, Paulino AC. Disease Control and Patterns of Failure After Proton Beam Therapy for Rhabdomyosarcoma. Int J Radiat Oncol Biol Phys 109(3):718-725, 2021. e-Pub 2021. PMID: 33516439.
119. De B, Kaiser KW, Ludmir EB, Yeboa DN, Tang C, Hoffman KE, Liao Z, Koong AC, Smith BD. Radiotherapy clinical trial enrollment during the COVID-19 pandemic. Acta Oncol 60(3):312-315, 2021. e-Pub 2021. PMID: 33356801.
120. Pasalic D, Fuller CD, Mainwaring W, Lin TA, Miller AB, Jethanandani A, Espinoza AF, Grossberg AJ, Jagsi R, Das P, Koong AC, Rödel C, Fokas E, Thomas CR, Minsky BD, Ludmir EB. Detecting the Dark Matter of Unpublished Clinical Cancer Studies: An Analysis of Phase 3 Randomized Controlled Trials. Mayo Clin Proc 96(2):420-426, 2021. e-Pub 2021. PMID: 33549260.
121. Patel RR, Verma V, Fuller CD, McCaw ZR, Ludmir EB. Transparency in reporting of phase 3 cancer clinical trial results. Acta Oncol 60(2):191-194, 2021. e-Pub 2021. PMID: 33307924.
122. Ludmir EB, McCaw ZR, Wei LJ. Re: Karim Fizazi, Charles G. Drake, Tomasz M. Beer, et al. Final Analysis of the Ipilimumab Versus Placebo Following Radiotherapy Phase III Trial in Postdocetaxel Metastatic Castration-resistant Prostate Cancer Identifies an Excess of Long-term Survivors. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2020.07.032: Interpreting the Effect of Ipilimumab Following Radiotherapy for Patients with Postdocetaxel Metastatic Castration-resistant Prostate Cancer. Eur Urol 79(1):e10-e11, 2021. e-Pub 2021. PMID: 33109378.
123. Abi Jaoude J, Kouzy R, Minsky BD, Fuller CD, Yuan Y, Do KA, Taniguchi CM, Ludmir EB. Sponsor-involved statistical analyses in Phase III cancer clinical trials. Int J Cancer 147(12):3579-3581, 2020. e-Pub 2020. PMID: 32621758.
124. Wright C, Verma V, Barsky AR, Haque W, Polamraju PV, Ludmir EB, Zaorsky NG, Lehrer EJ, Trifiletti DM, Grover S, Friedberg JS, Simone CB. Quantitation and predictors of short-term mortality following extrapleural pneumonectomy, pleurectomy/decortication, and nonoperative management for malignant pleural mesothelioma. J Thorac Dis 12(11):6476-6493, 2020. e-Pub 2020. PMID: 33282350.
125. Patel R, Ludmir EB, Miccio JA, Menon H, Barsky AR, Mesko SM, Kodali M, Lautenschlaeger T, Adeberg S, Simone CB, Verma V. Disease-Related Outcomes and Toxicities of Intensity Modulated Radiation Therapy After Lung-Sparing Pleurectomy for Malignant Pleural Mesothelioma: A Systematic Review. Pract Radiat Oncol 10(6):423-433, 2020. e-Pub 2020. PMID: 32088429.
126. Barsky AR, Ahern CA, Venigalla S, Verma V, Anstadt EJ, Wright CM, Ludmir EB, Berlind CG, Lindsay WD, Grover S, Cengel KA, Simone CB. Gender-based Disparities in Receipt of Care and Survival in Malignant Pleural Mesothelioma. Clin Lung Cancer 21(6):e583-e591, 2020. e-Pub 2020. PMID: 32611504.
127. Kouzy R, Abi Jaoude J, Mainwaring W, Lin TA, Miller AB, Jethanandani A, Espinoza AF, Verma V, Fuller CD, Minsky BD, Rödel C, Taniguchi CM, Ludmir EB. Professional Medical Writer Assistance in Oncology Clinical Trials. Oncologist 25(11):e1812-e1815, 2020. e-Pub 2020. PMID: 32885898.
128. Lin TA, Ludmir EB, Liao KP, McAleer MF, Bishop AJ, Grosshans D, McGovern S, Woodhouse KD, Paulino AC, Yeboa DN. Relationship between treatment center case volume and survival for localized Ewing sarcoma: The role of radiotherapy timing. Pediatr Blood Cancer 67(11):e28685, 2020. e-Pub 2020. PMID: 32881378.
129. Grant SR, Lin TA, Miller AB, Mainwaring W, Espinoza AF, Jethanandani A, Walker GV, Smith BD, Ashleigh Guadagnolo B, Jagsi R, David Fuller C, Thomas CR, Ludmir EB. Racial and Ethnic Disparities Among Participants in US-Based Phase 3 Randomized Cancer Clinical Trials. JNCI Cancer Spectr 4(5):pkaa060, 2020. e-Pub 2020. PMID: 33225207.
130. Mainwaring W, Ludmir EB, Kim SJ. Reader comments. Proc (Bayl Univ Med Cent) 34(1):221-222, 2020. e-Pub 2020. PMID: 33456202.
131. Pasalic D, Tang C, Jagsi R, Fuller CD, Koong AC, Ludmir EB. Association of Industry Sponsorship With Cancer Clinical Trial Accrual. JAMA Oncol 6(10):1625-1627, 2020. e-Pub 2020. PMID: 32815984.
132. Abi Jaoude J, Kouzy R, Mainwaring W, Lin TA, Miller AB, Jethanandani A, Espinoza AF, Pasalic D, Verma V, VanderWalde NA, Smith BD, Smith GL, Fuller CD, Das P, Minsky BD, Rödel C, Fokas E, Jagsi R, Thomas CR, Subbiah IM, Taniguchi CM, Ludmir EB. Performance Status Restriction in Phase III Cancer Clinical Trials. J Natl Compr Canc Netw 18(10):1322-1326, 2020. e-Pub 2020. PMID: 33022640.
133. Noticewala SS, Ludmir EB, Eng C, Holliday EB, Minsky BD, Morris VK, Das P. Anal cancer treatment regimen considerations for the COVID-19 era: In regard to Tchelebi et al. Radiother Oncol 151:56-57, 2020. e-Pub 2020. PMID: 32710989.
134. Abi Jaoude J, Kouzy R, El Alam MB, Subbiah V, Taniguchi CM, Ludmir EB, Lin TA. Exclusion of Older Adults in COVID-19 Clinical Trials. Mayo Clin Proc 95(10):2293-2294, 2020. e-Pub 2020. PMID: 33012364.
135. Fuller CD, van Dijk LV, Thompson RF, Scott JG, Ludmir EB, Thomas CR. Meeting the Challenge of Scientific Dissemination in the Era of COVID-19: Toward a Modular Approach to Knowledge-Sharing for Radiation Oncology. Int J Radiat Oncol Biol Phys 108(2):496-505, 2020. e-Pub 2020. PMID: 32890543.
136. Lin TA, Fuller CD, Verma V, Mainwaring W, Espinoza AF, Miller AB, Jethanandani A, Pasalic D, Das P, Minsky BD, Thomas CR, Fogelman DR, Subbiah V, Subbiah IM, Ludmir EB. Trial Sponsorship and Time to Reporting for Phase 3 Randomized Cancer Clinical Trials. Cancers (Basel) 12(9), 2020. e-Pub 2020. PMID: 32947844.
137. Ludmir EB, McCaw ZR, Fuller CD, Wei LJ. Progression-free survival in the ICON8 trial. Lancet 396(10253):756, 2020. e-Pub 2020. PMID: 32919510.
138. Diefenhardt M, Ludmir EB, Hofheinz RD, Ghadimi M, Minsky BD, Rödel C, Fokas E. Association of Treatment Adherence With Oncologic Outcomes for Patients With Rectal Cancer: A Post Hoc Analysis of the CAO/ARO/AIO-04 Phase 3 Randomized Clinical Trial. JAMA Oncol 6(9):1416-1421, 2020. e-Pub 2020. PMID: 32644104.
139. Verma V, Ludmir EB, Mesko SM, Brooks ED, Augustyn A, Milano MT, Lin SH, Chang JY, Welsh JW. Commercial Insurance Coverage of Advanced Radiation Therapy Techniques Compared With American Society for Radiation Oncology Model Policies. Pract Radiat Oncol 10(5):324-329, 2020. e-Pub 2020. PMID: 31446147.
140. Pasalic D, McGinnis GJ, Fuller CD, Grossberg AJ, Verma V, Mainwaring W, Miller AB, Lin TA, Jethanandani A, Espinoza AF, Diefenhardt M, Das P, Subbiah V, Subbiah IM, Jagsi R, Garden AS, Fokas E, Rödel C, Thomas CR, Minsky BD, Ludmir EB. Progression-free survival is a suboptimal predictor for overall survival among metastatic solid tumour clinical trials. Eur J Cancer 136:176-185, 2020. e-Pub 2020. PMID: 32702645.
141. McCaw ZR, Ludmir EB, Kim DH, Wei LJ. Further clinical interpretation and implications of KEYNOTE-048 findings. Lancet 396(10248):378-379, 2020. e-Pub 2020. PMID: 32771102.
142. Pasalic D, Betancourt-Cuellar SL, Taku N, Ludmir EB, Lu Y, Allen PK, Tang C, Antonoff MB, Fuller CD, Rosenthal DI, Morrison WH, Phan J, Garden AS, Welsh JW, Chang JY, Liao Z, Erasmus JJ, Nguyen QN. Outcomes and toxicities following stereotactic ablative radiotherapy for pulmonary metastases in patients with primary head and neck cancer. Head Neck 42(8):1939-1953, 2020. e-Pub 2020. PMID: 32129548.
143. Pasalic D, Ludmir EB, Allen PK, Thaker NG, Chapman BV, Hanna EY, Su SY, Ferrarotto R, Glisson BS, Reddy JP, Brandon Gunn G, Fuller CD, Phan J, Rosenthal DI, Morrison WH, Garden AS, Frank SJ. Patient-reported outcomes, physician-reported toxicities, and treatment outcomes in a modern cohort of patients with sinonasal cancer treated using proton beam therapy. Radiother Oncol 148:258-266, 2020. e-Pub 2020. PMID: 32417351.
144. Noticewala SS, Ludmir EB, Bishop AJ, Chung C, Ghia AJ, Grosshans D, McGovern S, Paulino AC, Wang C, Woodhouse KD, Yeboa DN, Prabhu SS, Weathers SP, Das P, Koong AC, McAleer MF, Li J. Radiation for Glioblastoma in the Era of Coronavirus Disease 2019 (COVID-19): Patient Selection and Hypofractionation to Maximize Benefit and Minimize Risk. Adv Radiat Oncol 5(4):743-745, 2020. e-Pub 2020. PMID: 32775785.
145. Kouzy R, Abi Jaoude J, Garcia Garcia CJ, El Alam MB, Taniguchi CM, Ludmir EB. Characteristics of the Multiplicity of Randomized Clinical Trials for Coronavirus Disease 2019 Launched During the Pandemic. JAMA Netw Open 3(7):e2015100, 2020. e-Pub 2020. PMID: 32658285.
146. Kouzy R, Abi Jaoude J, Yue J, Maldonado JA, Taniguchi CM, Ludmir EB, Colbert LE. Applying to Radiation Oncology Amid a Pandemic. Adv Radiat Oncol 5(4):777-779, 2020. e-Pub 2020. PMID: 32775792.
147. Noticewala SS, Ludmir EB, Li J, McAleer MF. In Reply to Rathod et al. Adv Radiat Oncol 5(4):748, 2020. e-Pub 2020. PMID: 32775787.
148. Noticewala SS, Koong AC, Bloom ES, Choi S, Chronowski G, Ghafar RA, Guadagnolo BA, Gunn GB, Klopp A, Lee P, Li J, Liao Z, Ludmir EB, McAleer MF, Nguyen QN, Ning MS, Robinson IJ, Rosenthal DI, Shah SJ, Woodward WA, Zaebst DJ, Dabaja BS, Das P. Radiation Oncology Strategies to Flatten the Curve During the Coronavirus Disease 2019 (COVID-19) Pandemic: Experience From a Large Tertiary Cancer Center. Adv Radiat Oncol 5(4):567-572, 2020. e-Pub 2020. PMID: 32775771.
149. Elhammali A, Amini B, Ludmir EB, Gunther JR, Milgrom SA, Pinnix CC, Andraos T, Yoder A, Weber D, Orlowski R, Manasanch E, Patel K, Strati P, Nair R, Lee HC, Thomas S, Iyer S, Kaufmann G, Garg N, Dabaja BS. New paradigm for radiation in multiple myeloma: lower yet effective dose to avoid radiation toxicity. Haematologica 105(7):e355-e357, 2020. e-Pub 2020. PMID: 31919088.
150. Gjyshi O, Boyce-Fappiano D, Pezzi TA, Ludmir EB, Xiao L, Kaseb A, Amini B, Yeboa DN, Bishop AJ, Li J, Rhines LD, Tatsui CE, Briere TM, Ghia AJ. Spine stereotactic radiosurgery for metastases from hepatobiliary malignancies: patient selection using PRISM scoring. J Neurooncol 148(2):327-334, 2020. e-Pub 2020. PMID: 32358642.
151. Corrigan KL, Mainwaring W, Miller AB, Lin TA, Jethanandani A, Espinoza AF, Piotrowski M, Fuller CD, Stauder MC, Shaitelman SF, Perkins GH, Woodward WA, Giordano SH, Smith BD, Ludmir EB. Exclusion of Men from Randomized Phase III Breast Cancer Clinical Trials. Oncologist 25(6):e990-e992, 2020. e-Pub 2020. PMID: 32272505.
152. Huang B, Wei LJ, Ludmir EB. Estimating Treatment Effect as the Primary Analysis in a Comparative Study: Moving Beyond P Value. J Clin Oncol 38(17):2001-2002, 2020. e-Pub 2020. PMID: 32315271.
153. Grant SR, Noticewala SS, Mainwaring W, Lin TA, Miller AB, Jethanandani A, Espinoza AF, Gunn GB, Fuller CD, Thomas CR, Portelance L, Ludmir EB. Non-English language validation of patient-reported outcome measures in cancer clinical trials. Support Care Cancer 28(6):2503-2505, 2020. e-Pub 2020. PMID: 32189098.
154. Fokas E, Glynne-Jones R, Appelt A, Beets-Tan R, Beets G, Haustermans K, Marijnen C, Minsky BD, Ludmir E, Quirke P, Sebag-Montefiore D, Garcia-Aguilar J, Gambacorta MA, Valentini V, Buyse M, Rödel C. Outcome measures in multimodal rectal cancer trials. Lancet Oncol 21(5):e252-e264, 2020. e-Pub 2020. PMID: 32359501.
155. Ludmir EB, McCaw ZR, Kim DH, Tian L, Wei LJ. Fulvestrant plus capivasertib for metastatic breast cancer. Lancet Oncol 21(5):e233, 2020. e-Pub 2020. PMID: 32359498.
156. Menon H, Patel RR, Ludmir EB, Muralidhar V, Cushman TR, Amini A, Seyedin SN, Nguyen PL, Verma V. Local management of preinvasive and clinical T1-3 penile cancer: utilization of diverse treatment modalities. Future Oncol 16(14):955-960, 2020. e-Pub 2020. PMID: 32301342.
157. Colbert LE, Kouzy R, Abi Jaoude J, Ludmir EB, Taniguchi CM. Cancer Research after COVID-19: Where Do We Go from Here?. Cancer Cell 37(5):637-638, 2020. e-Pub 2020. PMID: 32396859.
158. Ludmir EB, Subbiah IM, Mainwaring W, Miller AB, Lin TA, Jethanandani A, Espinoza AF, Mandel JJ, Fang P, Smith BD, Smith GL, Pinnix CC, Sedrak MS, Kimmick GG, Stinchcombe TE, Jagsi R, Thomas CR, Fuller CD, VanderWalde NA. Decreasing incidence of upper age restriction enrollment criteria among cancer clinical trials. J Geriatr Oncol 11(3):451-454, 2020. e-Pub 2020. PMID: 31711757.
159. Patel RR, Verma V, Miller AB, Lin TA, Jethanandani A, Espinoza AF, Mainwaring W, Augustyn A, Fuller CD, Sulman EP, Yeboa DN, Chung CC, McAleer MF, Li J, Yoshor D, de Groot JF, Mandel JJ, Ludmir EB. Exclusion of patients with brain metastases from cancer clinical trials. Neuro Oncol 22(4):577-579, 2020. e-Pub 2020. PMID: 31900480.
160. Ludmir EB, Espinoza AF, Jethanandani A, Lin TA, Mainwaring W, Miller AB, Das P. Incidence and correlates of HIV exclusion criteria in cancer clinical trials. Int J Cancer 146(8):2362-2364, 2020. e-Pub 2020. PMID: 31746465.
161. Patel RR, Ludmir EB, Augustyn A, Zaorsky NG, Lehrer EJ, Ryali R, Trifiletti DM, Adeberg S, Amini A, Verma V. De-intensification of therapy in human papillomavirus associated oropharyngeal cancer: A systematic review of prospective trials. Oral Oncol 103:104608, 2020. e-Pub 2020. PMID: 32163853.
162. Ludmir EB, Espinoza AF, Jethanandani A, Lin TA, Mainwaring W, Miller AB, Das P. Reporting and exclusion of sexual and gender minorities in cancer clinical trials. Int J Cancer 146(8):2360-2361, 2020. e-Pub 2020. PMID: 31584188.
163. McCaw ZR, Wei LJ, Ludmir EB. Interpreting the impact of apalutamide on overall survival among patients with non-metastatic castration-resistant prostate cancer. Ann Oncol 31(3):438-440, 2020. e-Pub 2020. PMID: 32067688.
164. Ludmir EB, Fuller CD, Moningi S, Mainwaring W, Lin TA, Miller AB, Jethanandani A, Espinoza AF, Verma V, Smith BD, Smith GL, VanderWalde NA, Holliday EB, Guadagnolo BA, Stinchcombe TE, Jagsi R, Gomez DR, Minsky BD, Rödel C, Fokas E. Sex-Based Disparities Among Cancer Clinical Trial Participants. J Natl Cancer Inst 112(2):211-213, 2020. e-Pub 2020. PMID: 31350545.
165. Diefenhardt M, Ludmir EB, Hofheinz RD, Ghadimi M, Minsky BD, Rödel C, Fokas E. Association of Sex With Toxic Effects, Treatment Adherence, and Oncologic Outcomes in the CAO/ARO/AIO-94 and CAO/ARO/AIO-04 Phase 3 Randomized Clinical Trials of Rectal Cancer. JAMA Oncol 6(2):294-296, 2020. e-Pub 2020. PMID: 31804659.
166. Mitchell KG, Farooqi A, Ludmir EB, Corsini EM, Zhang J, Sepesi B, Vaporciyan AA, Swisher SG, Heymach JV, Zhang J, Gomez DR, Antonoff MB. Improved Overall Survival With Comprehensive Local Consolidative Therapy in Synchronous Oligometastatic Non-Small-Cell Lung Cancer. Clin Lung Cancer 21(1):37-46.e7, 2020. e-Pub 2020. PMID: 31447303.
167. Pasalic D, Prajapati S, Ludmir EB, Tang C, Choi S, Kudchadker R, Frank SJ. Outcomes and Toxicities of Proton and Photon Radiation Therapy for Testicular Seminoma. Int J Part Ther 7(2):11-20, 2020. e-Pub 2020. PMID: 33274253.
168. Ludmir EB, Jethanandani A, Mainwaring W, Miller AB, Lin TA, Espinoza AF, Verma V, VanderWalde NA, Grossberg AJ, Guadagnolo BA, Koong AC, Jagsi R, Thomas CR, Fuller CD. The Trials (and Tribulations) of Complementary and Alternative Medicine in Oncology. J Natl Cancer Inst 111(12):1358-1360, 2019. e-Pub 2019. PMID: 31165160.
169. Ludmir EB, Mainwaring W, Lin TA, Miller AB, Jethanandani A, Espinoza AF, Mandel JJ, Lin SH, Smith BD, Smith GL, VanderWalde NA, Minsky BD, Koong AC, Stinchcombe TE, Jagsi R, Gomez DR, Thomas CR, Fuller CD. Factors Associated With Age Disparities Among Cancer Clinical Trial Participants. JAMA Oncol 5(12):1769-1773, 2019. e-Pub 2019. PMID: 31158272.
170. Buszek SM, Ludmir EB, Grosshans DR, McAleer MF, McGovern SL, Harrison DJ, Okcu MF, Chintagumpala MM, Mahajan A, Paulino AC. Patterns of failure and toxicity profile following proton beam therapy for pediatric bladder and prostate rhabdomyosarcoma. Pediatr Blood Cancer 66(11):e27952, 2019. e-Pub 2019. PMID: 31397065.
171. Youssef M, Ludmir EB, Mandel JJ, Patel AJ, Jalali A, Treiber J, Wu J, McAleer MF, de Groot JF. Treatment strategies for glioblastoma in older patients: age is just a number. J Neurooncol 145(2):357-364, 2019. e-Pub 2019. PMID: 31643011.
172. Moningi S, Ludmir EB, Polamraju P, Williamson T, Melkun MM, Herman JD, Krishnan S, Koay EJ, Koong AC, Minsky BD, Smith GL, Taniguchi C, Das P, Holliday EB. Definitive hyperfractionated, accelerated proton reirradiation for patients with pelvic malignancies. Clin Transl Radiat Oncol 19:59-65, 2019. e-Pub 2019. PMID: 31517071.
173. Ludmir EB, McCaw ZR, Grossberg AJ, Wei LJ, Fuller CD. Quantifying the benefit of non-small-cell lung cancer immunotherapy. Lancet 394(10212):1904, 2019. e-Pub 2019. PMID: 31777387.
174. Ludmir EB, Mainwaring W, Miller AB, Lin TA, Jethanandani A, Espinoza AF, Holliday EB. Women's Representation Among Lead Investigators of Clinical Trials in Oncology. JAMA Oncol 5(10):1501-1502, 2019. e-Pub 2019. PMID: 31393530.
175. Khattab A, Patruni S, Abel S, Hasan S, Ludmir EB, Finley G, Monga D, Wegner RE, Verma V. Long-term outcomes by response to neoadjuvant chemotherapy or chemoradiation in patients with resected pancreatic adenocarcinoma. J Gastrointest Oncol 10(5):918-927, 2019. e-Pub 2019. PMID: 31602330.
176. Elhammali A, Milgrom SA, Amini B, Gunther JR, Yoder A, Ludmir EB, Moon B, Weber DM, Thomas SK, Garg N, Manasanch EE, Patel KK, Orlowski RZ, Lee HC, Bird JE, Satcher R, Lin P, Pinnix CC, Dabaja BS. Postoperative Radiotherapy for Multiple Myeloma of Long Bones: Should the Entire Rod Be Treated?. Clin Lymphoma Myeloma Leuk 19(8):e465-e469, 2019. e-Pub 2019. PMID: 31133526.
177. Gjyshi O, Ludmir EB, Pezzi TA, Boyce-Fappiano D, Dursteler AE, Mitin T, Lin SH. Evolving Practice Patterns in the Use of Prophylactic Cranial Irradiation for Extensive-Stage Small Cell Lung Cancer. JAMA Netw Open 2(8):e199135, 2019. e-Pub 2019. PMID: 31411707.
178. Verma V, Wegner RE, Ludmir EB, Hasan S, Colonias A, Grover S, Friedberg JS, Simone CB. Management of Malignant Pleural Mesothelioma in the Elderly Population. Ann Surg Oncol 26(8):2357-2366, 2019. e-Pub 2019. PMID: 31011908.
179. Ludmir EB, Mahajan A, Ahern V, Ajithkumar T, Alapetite C, Bernier-Chastagner V, Bindra RS, Bishop AJ, Bolle S, Brown PD, Carrie C, Chalmers AJ, Chang EL, Chung C, Dieckmann K, Esiashvili N, Gandola L, Ghia AJ, Gondi V, Grosshans DR, Harrabi SB, Horan G, Indelicato DJ, Jalali R, Janssens GO, Krause M, Laack NN, Laperriere N, Laprie A, Li J, Marcus KJ, McGovern SL, Merchant TE, Merrell KW, Padovani L, Parkes J, Paulino AC, Schwarz R, Shih HA, Souhami L, Sulman EP, Taylor RE, Thorp N, Timmermann B, Wheeler G, Wolden SL, Woodhouse KD, Yeboa DN, Yock TI, Kortmann RD, McAleer MF. Assembling the brain trust: the multidisciplinary imperative in neuro-oncology. Nat Rev Clin Oncol 16(8):521-522, 2019. e-Pub 2019. PMID: 31150024.
180. Ludmir EB, Adlakha EK, Chun SG, Reed VK, Arzu IY, Ahmad N, Bloom E, Chronowski GM, Delclos ME, Mayo LL, Schlembach PJ, Liao Z, Koong AC, Herman JM, Shah SJ. Enhancing clinical trial enrollment at MD Anderson Cancer Center satellite community campuses. Acta Oncol 58(8):1135-1137, 2019. e-Pub 2019. PMID: 30958082.
181. Ludmir EB, Elahi MA, Guadagnolo BA. Reducing Firearm Injuries and Deaths in the United States. Ann Intern Med 170(12):911, 2019. e-Pub 2019. PMID: 31207633.
182. Lin TA, Ludmir EB, Liao KP, McAleer MF, Grosshans DR, McGovern SL, Bishop AJ, Woodhouse KD, Paulino AC, Yeboa DN. Timing of Local Therapy Affects Survival in Ewing Sarcoma. Int J Radiat Oncol Biol Phys 104(1):127-136, 2019. e-Pub 2019. PMID: 30593906.
183. Ludmir EB, Mahajan A, Paulino AC, Jones JY, Ketonen LM, Su JM, Grosshans DR, McAleer MF, McGovern SL, Lassen-Ramshad YA, Adesina AM, Dauser RC, Weinberg JS, Chintagumpala MM. Increased risk of pseudoprogression among pediatric low-grade glioma patients treated with proton versus photon radiotherapy. Neuro Oncol 21(5):686-695, 2019. e-Pub 2019. PMID: 30753704.
184. Ludmir EB, Grosshans DR, McAleer MF, McGovern SL, Harrison DJ, Okcu MF, Chintagumpala MM, Mahajan A, Paulino AC. Patterns of failure following proton beam therapy for head and neck rhabdomyosarcoma. Radiother Oncol 134:143-150, 2019. e-Pub 2019. PMID: 31005208.
185. Pinnix CC, Milgrom SA, Cheah CY, Gunther JR, Ludmir EB, Wogan CF, Nastoupil LJ, Neelapu SS, Westin J, Lee HJ, Iyer SP, Steiner RE, Fayad LE, Fowler NH, Wang ML, Samaniego F, Rodriguez MA, Rich AE, Medeiros LJ, Dabaja BS. Favorable outcomes with de-escalated radiation therapy for limited-stage nodular lymphocyte-predominant Hodgkin lymphoma. Blood Adv 3(9):1356-1367, 2019. e-Pub 2019. PMID: 31036721.
186. Ludmir EB, Milgrom SA, Pinnix CC, Gunther JR, Westin J, Fayad LE, Khoury JD, Medeiros LJ, Dabaja BS, Nastoupil LJ. Emerging Treatment Strategies for Primary Breast Extranodal Marginal Zone Lymphoma of Mucosa-associated Lymphoid Tissue. Clin Lymphoma Myeloma Leuk 19(4):244-250, 2019. e-Pub 2019. PMID: 30686775.
187. Mandel JJ, Youssef M, Nam J, Patel AJ, Jalali A, Ludmir EB, Liu D, Wu J, Armstrong G, Huse J, Bondy M, de Groot JF. Effect of health disparities on overall survival of patients with glioblastoma. J Neurooncol 142(2):365-374, 2019. e-Pub 2019. PMID: 30671709.
188. Ludmir EB, Mandel JJ, McAleer MF, de Groot JF. Disparities along the glioblastoma clinical trials landscape. Neuro Oncol 21(2):285-286, 2019. e-Pub 2019. PMID: 30476295.
189. Ludmir EB, Jethanandani A, Mainwaring W, Miller AB, Lin TA, Espinoza AF, Grossberg AJ, Fuller CD. Assessing the Impact of Complementary and Alternative Medicine Trials in Oncology. Integr Cancer Ther 18:1534735419859089, 2019. e-Pub 2019. PMID: 31220950.
190. Ludmir EB, Milgrom SA, Pinnix CC, Gunther JR, Westin J, Oki Y, Fayad LE, Medeiros LJ, Dabaja BS, Nastoupil LJ. Primary breast diffuse large B-cell lymphoma: treatment strategies and patterns of failure^{. Leuk Lymphoma 59(12):2896-2903, 2018. e-Pub 2018. PMID: 29697005.}
191. Pinnix CC, Wirth A, Milgrom SA, Andraos TY, Aristophanous M, Pham M, Hancock D, Ludmir EB, Gunther JR, Fanale MA, Oki Y, Nastoupil L, Chuang HH, Mikhaeel NG, Dabaja BS. Omitting cardiophrenic lymph nodes in the treatment of patients with Hodgkin lymphoma via modified involved-site radiation therapy. Leuk Lymphoma 59(11):2650-2659, 2018. e-Pub 2018. PMID: 29616834.
192. Mandel JJ, Youssef M, Ludmir E, Yust-Katz S, Patel AJ, De Groot JF. Highlighting the need for reliable clinical trials in glioblastoma. Expert Rev Anticancer Ther 18(10):1031-1040, 2018. e-Pub 2018. PMID: 29973092.
193. Smith GL, Das P, Herman JM, Koay EJ, Koong AC, Grossberg A, Ludmir E. Comparing Ablative Modalities for Hepatocellular Carcinoma: Cautions in Interpreting Big Data. J Clin Oncol 36(24):2565-2566, 2018. e-Pub 2018. PMID: 29945520.
194. Ludmir EB, Paulino AC, Grosshans DR, McAleer MF, McGovern SL, Huh WW, Okcu MF, Harrell LM, Mahajan A. Regional Nodal Control for Head and Neck Alveolar Rhabdomyosarcoma. Int J Radiat Oncol Biol Phys 101(1):169-176, 2018. e-Pub 2018. PMID: 29477293.
195. Ludmir EB, Gutschenritter T, Pinnix CC, Gunther JR, Nastoupil LJ, Khoury JD, Medeiros LJ, Dabaja BS, Milgrom SA. Coincident primary breast lymphoma and gastrointestinal stromal tumor: case series and molecular mechanisms. Onco Targets Ther 11:8937-8942, 2018. e-Pub 2018. PMID: 30573980.
196. Ng SP, Ludmir EB, Oyervides MA, Wu RY, Frank S, Gunn GB. Combination Intensity Modulated Proton Therapy and Passive Scatter Boost for Rapidly Progressing Nasal Cavity Squamous Cell Carcinoma. Cureus 9(9):e1685, 2017. e-Pub 2017. PMID: 29152442.
197. Ludmir EB, Elahi MA, Richman BD. The physician as dictator. Lancet 390(10099):1023, 2017. e-Pub 2017. PMID: 28901930.
198. Keehn A, Ludmir E, Taylor J, Rabbani F. Incidence of bladder cancer after radiation for prostate cancer as a function of time and radiation modality. World J Urol 35(5):713-720, 2017. e-Pub 2017. PMID: 27629559.
199. Ludmir EB, McCall SJ, Cardona DM, Perkinson KR, Guy CD, Zhang X. Mixed Adenoneuroendocrine Carcinoma, Amphicrine Type, of the Small Bowel. Am J Clin Pathol 145(5):703-9, 2016. e-Pub 2016. PMID: 27124941.
200. Ludmir EB, Arya R, Wu Y, Palta M, Willett CG, Czito BG. Role of Adjuvant Radiotherapy in Locally Advanced Colonic Carcinoma in the Modern Chemotherapy Era. Ann Surg Oncol 23(3):856-62, 2016. e-Pub 2016. PMID: 26480849.
201. Ludmir EB, Robey B, Shelby E, Patel-Nguyen SV, Rittershaus A, Contarino MR. Skeletal muscle metastasis from signet ring cell esophageal adenocarcinoma. Transl Gastroenterol Hepatol 1:37, 2016. e-Pub 2016. PMID: 28138604.
202. Ludmir EB, Stephens SJ, Palta M, Willett CG, Czito BG. Human papillomavirus tumor infection in esophageal squamous cell carcinoma. J Gastrointest Oncol 6(3):287-95, 2015. e-Pub 2015. PMID: 26029456.
203. Ludmir EB, Palta M, Zhang X, Wu Y, Willett CG, Czito BG. Incidence and prognostic impact of high-risk HPV tumor infection in cervical esophageal carcinoma. J Gastrointest Oncol 5(6):401-7, 2014. e-Pub 2014. PMID: 25436117.
204. Ludmir EB, McCall SJ, Czito BG, Palta M. Radiosensitive orbital metastasis as presentation of occult colonic adenocarcinoma. BMJ Case Rep 2014, 2014. e-Pub 2014. PMID: 25240005.
205. Card JP, Kobiler O, Ludmir EB, Desai V, Sved AF, Enquist LW. A dual infection pseudorabies virus conditional reporter approach to identify projections to collateralized neurons in complex neural circuits. PLoS One 6(6):e21141, 2011. e-Pub 2011. PMID: 21698154.
206. Kobiler O, Brodersen P, Taylor MP, Ludmir EB, Enquist LW. Herpesvirus replication compartments originate with single incoming viral genomes. mBio 2(6), 2011. e-Pub 2011. PMID: 22186611.
207. Ludmir EB, Enquist LW. Viral genomes are part of the phylogenetic tree of life. Nat Rev Microbiol 7(8):615; author reply 615, 2009. e-Pub 2009. PMID: 19561625.

Review Articles

1. Chang, E, Sherry, AD, Liermann, J, Abdollahi, A, Tzeng, CD, Tang, C, Aguilera, T, Koay, EJ, Das, P, Koong, A, Pant, S, Ludmir, EB. Evolving Paradigms in the Treatment of Oligometastatic Pancreatic Ductal Adenocarcinoma. Journal of Gastrointestinal Cancer 56(1), 2025. e-Pub 2025. PMID: 39827280.
2. Aguilera, T, Elamir, AM, Ludmir, EB. Quality and Quantity. Seminars in radiation oncology 35(4):538-545, 2025. e-Pub 2025. PMID: 40935441.
3. Chuong, MD, Ashman, JB, Jethwa, K, Kharofa, J, Kim, H, Koay, EJ, Ludmir, EB, Miller, ED, Nelson, BA, Reyngold, M, Sanford, NN, Chang, DT. Moving From the Background Toward the Spotlight. International Journal of Radiation Oncology Biology Physics 122(2):294-312, 2025. e-Pub 2025. PMID: 40032056.
4. Dudzinski, SO, Newman, NB, McIntyre, J, Engineer, R, Sanford, NN, Wo, JY, Seong, J, Guha, C, Chang, DT, Hong, TS, Dawson, LA, Koay, EJ, Ludmir, EB. Emerging evidence-based role for external-beam radiation therapy in hepatocellular carcinoma. The Lancet Gastroenterology and Hepatology 10(4):387-398, 2025. e-Pub 2025. PMID: 39993402.
5. Samuel R, Knight SR, Adams RA, Das P, Dorth JA, Finch D, Guren M, Hawkins M, Moug S, Rajdev L, Sebag-Montefiore D, Renehan AG, Fish R, Rodriguez-Bigas MA, Adusumilli P, Mohamed AA, Gallego MA, Angenete E, Appelt A, Berbee M, Brogden D, Brown P, Buckley L, Casanova N, Cooper R, Couto N, Coyne PE, Cuming T, Deijin C, Dennis K, Eng C, Gilbert A, Gilbert D, Goodman KA, Jadon R, Johnsson A, Kar A, Ludmir EB, Lydrup ML, Lyra-Gonzalez I, Manfrida S, Muirhead R, O'Dwyer ST, Rackley T, Raszewski L, Samuel L, Saunders MP, Scarsbrook A, Segelov E, Simmons T. International consensus to define outcomes for trials of chemoradiotherapy for anal cancer (CORMAC-2). EClinicalMedicine 78, 2024. e-Pub 2024. PMID: 39720423.
6. Lin TA, Sherry AD, Ludmir EB. Challenges, Complexities, and Considerations in the Design and Interpretation of Late-Phase Oncology Trials. Semin Radiat Oncol 33(4):429-437, 2023. e-Pub 2023. PMID: 37684072.
7. Corrigan KL, Rooney MK, Kouzy R, Manzar G, Thomas CR, Ludmir EB. Selection and Prejudice: Addressing Clinical Trial Disparities With a Review of Current Shortcomings and Future Directions. Semin Radiat Oncol 33(4):367-373, 2023. e-Pub 2023. PMID: 37684066.
8. Koay, EJ, Javle, M, Belknap, M, Derasari, S, Roach, MA, Ludmir, EB. What Role Does Radiotherapy Play in the Molecular Era for Intrahepatic Cholangiocarcinoma?. Cancer Journal (United States) 29(5):272-278, 2023. e-Pub 2023. PMID: 37796645.
9. Amini A, Morris L, Ludmir EB, Movsas B, Jagsi R, VanderWalde NA. Radiation Therapy in Older Adults With Cancer: A Critical Modality in Geriatric Oncology. J Clin Oncol 40(16):JCO2102656, 2022. e-Pub 2022. PMID: 35417248.
10. Bumanlag IM, Jaoude JA, Rooney MK, Taniguchi CM, Ludmir EB. Exclusion of Older Adults from Cancer Clinical Trials: Review of the Literature and Future Recommendations. Semin Radiat Oncol 32(2):125-134, 2022. e-Pub 2022. PMID: 35307114.
11. He K, Barsoumian HB, Bertolet G, Verma V, Leuschner C, Koay EJ, Ludmir EB, Hsu E, Pisipati E, Voss TA, Puebla-Osorio N, Cortez MA, Welsh JW. Novel Use of Low-Dose Radiotherapy to Modulate the Tumor Microenvironment of Liver Metastases. Front Immunol 12:812210, 2021. e-Pub 2021. PMID: 34975924.
12. Ludmir EB, Das P. Shifting sands: the role of radiotherapy for patients with gastric and gastroesophageal adenocarcinoma. Transl Gastroenterol Hepatol 6:50, 2021. e-Pub 2021. PMID: 34423171.
13. Abi Jaoude J, Kouzy R, Nguyen ND, Lin D, Noticewala SS, Ludmir EB, Taniguchi CM. Radiation therapy for patients with locally advanced pancreatic cancer: Evolving techniques and treatment strategies. Curr Probl Cancer 44(6):100607, 2020. e-Pub 2020. PMID: 32471736.
14. Kouzy R, Abi Jaoude J, Lin D, Nguyen ND, El Alam MB, Ludmir EB, Taniguchi CM. Patient-Reported Outcome Measures in Pancreatic Cancer Receiving Radiotherapy. Cancers (Basel) 12(9), 2020. e-Pub 2020. PMID: 32887363.
15. Abel S, Lee S, Ludmir EB, Verma V. Principles and Applications of Stereotactic Radiosurgery and Stereotactic Body Radiation Therapy. Hematol Oncol Clin North Am 33(6):977-987, 2019. e-Pub 2019. PMID: 31668215.
16. Ludmir EB, Grosshans DR, Woodhouse KD. Radiotherapy Advances in Pediatric Neuro-Oncology. Bioengineering (Basel) 5(4), 2018. e-Pub 2018. PMID: 30400370.
17. Ludmir EB, Palta M, Willett CG, Czito BG. Total neoadjuvant therapy for rectal cancer: An emerging option. Cancer 123(9):1497-1506, 2017. e-Pub 2017. PMID: 28295220.
18. Ludmir EB, Kachnic LA, Czito BG. Evolution and Management of Treatment-Related Toxicity in Anal Cancer. Surg Oncol Clin N Am 26(1):91-113, 2017. e-Pub 2017. PMID: 27889040.

Other Articles

1. Sherry AD, Msaouel P, Ludmir EB A meta-epidemiological analysis of post-hoc comparisons and primary endpoint interpretability among randomized noncomparative trials in clinical medicine. J Clin Epidemiol 175:111540, 2024. PMID: 39313076.
2. Sherry AD, Msaouel P, Kupferman GS, Lin TA, Abi Jaoude J, Kouzy R, El-Alam MB, Patel R, Koong A, Lin C, Passy AH, Miller AM, Beck EJ, Fuller CD, Meirson T, McCaw ZR, Ludmir EB Towards Treatment Effect Interpretability: A Bayesian Re-analysis of 194,129 Patient Outcomes Across 230 Oncology Trials. medRxiv, 2024. PMID: 39108512.
3. Sherry AD, Msaouel P, Miller AM, Lin TA, Kupferman GS, Jaoude JA, Kouzy R, El-Alam MB, Patel R, Koong A, Lin C, Meirson T, McCaw ZR, Ludmir EB Bayesian Interim Analysis and Efficiency of Phase III Randomized Trials. medRxiv, 2024. PMID: 38978666.

Book Chapters

1. Manzar, G, Abi Jaoude, J, Taniguchi, C, Koong, A, Koay, EJ, Ludmir, EB. Radiation Therapy for Pancreatic Cancer, 37-55, 2023.
2. Ludmir EB. Radiation Therapy for Pancreatic Cancer: Current and Evolving Paradigms. In: Pancreatic Cancer. SpringerLink, 2023.
3. Ludmir EB, Cooper BT, Paulino AC. Pediatric Sarcoma. In: Target Volume Delineation and Field Setup: A Practical Guide for Conformal and Intensity-Modulated Radiation Therapy (2nd edition), 2022.
4. Cooper BT, Ludmir, EB, Paulino AC. Pediatric Brain Tumors. In: Target Volume Delineation and Field Setup: A Practical Guide for Conformal and Intensity-Modulated Radiation Therapy (2nd edition; Lee NY, Lu JJ, Yu Y editors), 2022.
5. Ludmir EB, Verma V, Rana S, Chennupati S, Ord CB, Thomas Jr CR. Lower Gastrointestinal Cancers. In: Second Edition of Radiation Oncology Study Guide. Springer, 2021.
6. Verma V, Ludmir EB, Siddiqui F, Ord CB, Thomas Jr CR. Upper Gastrointestinal Cancers. In: Second Edition of Radiation Oncology Study Guide. Springer, 2021.
7. Ludmir EB, Paulino AC. Intracranial Germ Cell Tumor. In: First Edition of Pocket Radiation Oncology. Wolters Kluwer Health / Lippincott Williams & Wilkins, 2019.
8. Ludmir EB, Paulino AC. Ewing Sarcoma. In: First Edition of Pocket Radiation Oncology. Wolters Kluwer Health / Lippincott Williams & Wilkins, 2019.
9. Ludmir EB, Paulino AC. Wilms. In: First Edition of Pocket Radiation Oncology. Wolters Kluwer Health / Lippincott Williams & Wilkins, 2019.
10. Ludmir EB, Paulino AC. Miscellaneous Pediatrics. In: First Edition of Pocket Radiation Oncology. Wolters Kluwer Health / Lippincott Williams & Wilkins, 2019.
11. Ludmir EB, Paulino AC. Late Effects (Pediatric). In: First Edition of Pocket Radiation Oncology. Wolters Kluwer Health / Lippincott Williams & Wilkins, 2019.
12. Ludmir EB, Paulino AC. Rhabdomyosarcoma. In: First Edition of Pocket Radiation Oncology. Wolters Kluwer Health / Lippincott Williams & Wilkins, 2019.
13. Farooqi AS, Ludmir EB, Paulino AC. Neuroblastoma. In: First Edition of Pocket Radiation Oncology. Wolters Kluwer Health / Lippincott Williams & Wilkins, 2019.

Letters to the Editor

1. Yousef, M, Yousef, A, Hurd, MW, Balachandran Pillai, A, Chowdhury, S, Snyder, RA, Knafl, M, Lewis, RL, Roy, PM, Fanaeian, M, Albarouki, S, Castelnovo, LF, Peterson, J, Smaglo, BG, Wolff, RA, Pant, S, Willis, JA, Huey, RW, Overman, MJ, Tzeng, CW, Kim, M, Ikoma, N, Maxwell, JE, Katz, MH, Wang, H, Maitra, A, Koay, EJ, Ludmir, EB, Chen, A, Lopez, C, Ying, H, Shen, JY, Zhao, D. KRAS mutation detection by liquid biopsy for pancreatic ductal adenocarcinoma. Journal of Hematology and Oncology 18, 2025.
2. Sherry, AD, Ludmir, EB, Msaouel, P. Random Assignment, But Without Comparison. Journal of Clinical Oncology 43: 2836-2837, 2025.
3. Sherry, AD, Dudzinski, SO, Ludmir, EB. Clinical, ethical, and quality-of-life outcomes in unresectable hepatocellular carcinoma. The Lancet 406: 693-694, 2025.
4. Sherry, AD, Kaseb, A, Ludmir, EB. Local Control and Extended Survival in Locally Advanced Hepatocellular Carcinoma. JAMA Oncology 11: 670-671, 2025.
5. Wang, X, Ludmir, EB, Wei, LJ. Assessing Clinical Utility of Datopotamab Deruxtecan Versus Chemotherapy for Breast Cancer. Journal of Clinical Oncology 43: 2136-2137, 2025.
6. Sherry, AD, Lim, B, Ludmir, EB, Msaouel, P. Misunderstood trial design. The lancet oncology 26: e297, 2025.
7. Sherry, AD, Ludmir, EB, Msaouel, P. Sunitinib for the treatment of phaeochromocytomas and paragangliomas. The Lancet 405: 380-381, 2025.
8. Kouzy R, Ludmir EB, Hoffman KE, Jhingran A, Kuban DA. In Reply to Akhtar et al. Pract Radiat Oncol 14: 466-467, 2024.